Revenue
200 thousand USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 200000 USD Source
Market value
$49.82M
5,133,645 shares as of 2026-11-06, at $9.705 a share (INKT, IEX close on 2026-11-12) Primary-source evidence
28 filing records in this dataset, filed from 2021-09-14 to 2026-11-12. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-21.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
200 thousand USD
2026 Q3 · USD
-1,318.5%
2026 Q3 · %
-1.28 million USD
2026 Q3 · USD
7500000 USD
5103083 shares
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-7.16 million USD
2025-10-01 – 2026-09-30
73.6 thousand USD
2023-01-01 – 2023-12-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-12.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 10.79 million
–
Current period
−USD 12.49 million
–
-12494000 − -10785000 = -1709000 USD
-10785000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-12494000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 9.56 million
–
Current period
−USD 5.93 million
–
-5925168 − -9555476 = 3630308 USD
-9555476 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-5925168 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 16.24 million Exact valueExact value: -16238898 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.34 million Exact valueExact value: -8337770 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 95,212 Exact valueExact value: 95212 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.43 million Calculation and evidence-8337770 − 95212 USD Exact free cash flow: -8432982 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 30.21 million Exact valueExact value: -30212770 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.83 million Exact valueExact value: -12827117 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 248,983 Exact valueExact value: 248983 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.08 million Calculation and evidence-12827117 − 248983 USD Exact free cash flow: -13076100 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 27.99 million Exact valueExact value: -27991212 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.87 million Exact valueExact value: -18866843 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 250,046 Exact valueExact value: 250046 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.12 million Calculation and evidence-18866843 − 250046 USD Exact free cash flow: -19116889 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 22.46 million Exact valueExact value: -22458000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.76 million Exact valueExact value: -15762512 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 73,561 Exact valueExact value: 73561 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.84 million Calculation and evidence-15762512 − 73561 USD Exact free cash flow: -15836073 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 10.79 million Exact valueExact value: -10785000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.56 million Exact valueExact value: -9555476 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 12.49 million Exact valueExact value: -12494000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.93 million Exact valueExact value: -5925168 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
28 filings · 1,144 latest values · 1,144 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001840229, 1840229, INKT, edgar:1840229
Also known as AgenTus Therapeutics, Inc., MiNK Therapeutics, Inc.